Your browser doesn't support javascript.
loading
Efficacy of the FDA-approved cannabidiol on the development and persistence of temporal lobe epilepsy and complex focal onset seizures.
Reddy, Doodipala Samba; Mbilinyi, Robert H; Ramakrishnan, Sreevidhya.
Afiliación
  • Reddy DS; Department of Neuroscience and Experimental Therapeutics, School of Medicine, Texas A&M University Health Science Center, Bryan, TX, USA.; Texas A&M Health Institute of Pharmacology and Neurotherapeutics, Texas A&M University, Bryan, TX, USA. Electronic address: sambareddy@tamu.edu.
  • Mbilinyi RH; Department of Neuroscience and Experimental Therapeutics, School of Medicine, Texas A&M University Health Science Center, Bryan, TX, USA.
  • Ramakrishnan S; Department of Neuroscience and Experimental Therapeutics, School of Medicine, Texas A&M University Health Science Center, Bryan, TX, USA.; Texas A&M Health Institute of Pharmacology and Neurotherapeutics, Texas A&M University, Bryan, TX, USA.
Exp Neurol ; 359: 114240, 2023 01.
Article en En | MEDLINE | ID: mdl-36216124
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabidiol / Epilepsia / Epilepsia del Lóbulo Temporal Tipo de estudio: Prognostic_studies Límite: Animals / Child / Humans Idioma: En Revista: Exp Neurol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cannabidiol / Epilepsia / Epilepsia del Lóbulo Temporal Tipo de estudio: Prognostic_studies Límite: Animals / Child / Humans Idioma: En Revista: Exp Neurol Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos